SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-22-069337
Filing Date
2022-03-08
Accepted
2022-03-08 16:34:24
Documents
11

Document Format Files

Seq Description Document Type Size
1 S-3 d303279ds3.htm S-3 410954
2 EX-1.2 d303279dex12.htm EX-1.2 179555
3 EX-4.4 d303279dex44.htm EX-4.4 283016
4 EX-5.1 d303279dex51.htm EX-5.1 26296
5 EX-23.1 d303279dex231.htm EX-23.1 1976
6 EX-FILING FEES d303279dexfilingfees.htm EX-FILING FEES 30142
7 GRAPHIC g303279g0308072620374.jpg GRAPHIC 2357
8 GRAPHIC g303279g0308072620608.jpg GRAPHIC 1651
9 GRAPHIC g303279g04a37.jpg GRAPHIC 32281
10 GRAPHIC g303279g05b43.jpg GRAPHIC 133726
11 GRAPHIC g303279g06c59.jpg GRAPHIC 40261
  Complete submission text file 0001193125-22-069337.txt   1211337
Mailing Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404
Business Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404 650-525-5535 EXT.101
Terns Pharmaceuticals, Inc. (Filer) CIK: 0001831363 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-263370 | Film No.: 22722178
SIC: 2834 Pharmaceutical Preparations